Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial evaluating NoAL (HPMC) in combination with oxymetazoline for allergic rhinitis has completed.
-
FDA approval · 2015-09-22FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approves a supplemental application for CHILDRENS FLONASE ALLERGY RELIEF (fluticasone propionate) from Haleon US Holdings LLC, expanding…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Efficacy and Safety of HCP1102 Capsule [Phase 3]
Phase 3 trial evaluating the efficacy and safety of HCP1102 Capsule for asthma with allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis [Phase 4]
A Phase 4 clinical trial comparing montelukast plus fexofenadine versus montelukast plus levocetirizine for allergic rhinitis has completed.
-
FDA approval · 2015-09-16FDA Approved: FEXOFENADINE HCL — Original Application (AKRON PHARMA INC)
FDA approved Akron Pharma Inc's original ANDA for fexofenadine hydrochloride (Fexofenadine HCl), a generic antihistamine for allergic rhinit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-04FDA Approved: MONTELUKAST SODIUM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's Montelukast Sodium as a generic version under an Original Abbreviated New Drug Application. Montel…
-
CLINICAL_TRIALS research · 2015-09-02Clinical Trial Update: Acupuncture for Rhinitis Complicated With Asthma [NA]
An ongoing clinical trial investigates acupuncture for allergic rhinitis complicated by asthma; the sponsor is Jun-Yong Choi, with unclear t…
-
FDA approval · 2015-08-26FDA Approved: PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for Promethazine HCl, Phenylephrine HCl, and Codeine Phosphate. The product provid…
-
FDA approval · 2015-08-18FDA Approved: EPINASTINE HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for epinastine hydrochloride (generic product) by Somerset Therapeutics, LLC.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Dietary Arachidonic Acid, Obesity and Atopic Respiratory Disease
This clinical trial update reports the completion of a study investigating the effects of dietary arachidonic acid on obesity and atopic (al…
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848 [Phase 1]
Phase 1 tolerability and pharmacology proof-of-principle study of intranasal AZD8848 in allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Drug Use Investigation for XYZAL®
GlaxoSmithKline completed a Drug Use Investigation for XYZAL (cetirizine) investigating its use in allergic rhinitis, including perennial an…
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Effect of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial evaluating Qi-tonifying Chinese herbal products for the treatment of allergic rhinitis has been completed. The spon…
-
FDA approval · 2015-08-05FDA Approved: CETIRIZINE HYDROCHLORIDE (ALLERGY) — Original Application (Aurohealth LLC)
FDA approved Aurohealth LLC's generic cetirizine hydrochloride for allergy indications via an original ANDA submission.
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: The Effect of Exercises on Physiological Changes and Clinical Symptoms in Allergic Rhinitis Patients [NA]
A completed clinical trial assessed the effects of a structured exercise program on physiological measures and clinical symptoms in patients…
-
FDA approval · 2015-08-03FDA Approved: ZYRTEC-D — Supplemental Application (Kenvue Brands LLC)
The FDA approves a supplemental application for ZYRTEC-D (cetirizine hydrochloride and pseudoephedrine hydrochloride) from Kenvue Brands LLC…
-
FDA approval · 2015-07-31FDA Approved: LORATADINE — Original Application (WALGREEN COMPANY)
FDA approves Walgreens' original submission for Loratadine (ANDA 201865), granting generic approval for loratadine. Loratadine is an antihis…
-
FDA approval · 2015-07-31FDA Approved: MONTELUKAST SODIUM — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s montelukast sodium generic under an Original Application (ANDA 203432). The product is approved for th…
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis [Phase 3]
A Phase 3 non-inferiority, open-label, multicenter randomized trial assessing treatment for mild to moderate persistent allergic rhinitis ha…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Anti-inflammatory H1 Antihistamines Allergic Rhinitis [Phase 4]
Phase 4 trial update: anti-inflammatory H1 antihistamines for allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis [Phase 1]
This Phase 1 trial assessed absorption and tolerability of intranasal ketorolac tromethamine and evaluated whether oxymetazoline hydrochlori…
-
FDA approval · 2015-07-09FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion containing fexofenadine hydrochloride and pseudoephedrine hydro…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis [NA]
A clinical trial evaluating a leukotriene D4 nasal provocation test for allergic rhinitis has completed, with asthma listed among conditions…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR [Phase 4]
Phase 4 safety evaluation of Astepro nasal sprays (0.15% and 0.1%) in children aged >6 months to <6 years with allergic rhinitis; results we…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense [Phase 2]
Phase 2 trial comparing different up-dosing schedules of Osiris Phleum Pratense (timothy grass pollen extract) for allergic rhinitis with co…